Chemocentryx, Inc. is a company in the U.S. stock market and it is a holding in 57 U.S.-traded ETFs. CCXI has around 7.7M shares in the U.S. ETF market. The largest ETF holder of CCXI is the SPDR S&P Biotech ETF (XBI), with approximately 2.52M shares. Investors may also find of interest that the ETF with the largest allocation to CCXI stock is Invesco Dynamic Biotechnology & Genome ETF (PBE), with a portfolio weight of 1.57%. On average, U.S. ETFs allocate 0.14% of CCXI to their portfolios.
Additionally, CCXI is a favorite stock for Vanilla and Active ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with CCXI as a holding is the iShares U.S. Pharmaceuticals ETF (IHE), with a return of 5.37%.